New patent expiration for Endo Pharms drug NASCOBAL
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is […]
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Patent Expiration
New patent expiration for Eiger Biopharms drug ZOKINVY
Annual Drug Patent Expirations for ZOKINVY Zokinvy is a drug marketed by Eiger Biopharms and is included in one NDA.
New patent expiration for Eiger Biopharms drug ZOKINVY Read Post »
New patent expiration for Sun Pharm drug WINLEVI
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA.
New patent expiration for Sun Pharm drug WINLEVI Read Post »
New patent expiration for Zr Pharma drug RUBRACA
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Zr Pharma and is included in one NDA.
New patent expiration for Zr Pharma drug RUBRACA Read Post »
New patent expiration for Nalpropion drug CONTRAVE
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It
New patent expiration for Nalpropion drug CONTRAVE Read Post »
Drug Patent Expirations for the Week of July 14, 2024
XEGLYZE (abametapir) Hatchtech Patent: 8,212,038 Expiration: Jul 16, 2024 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of July 14, 2024 Read Post »
New patent expiration for Hatchtech drug XEGLYZE
Annual Drug Patent Expirations for XEGLYZE Xeglyze is a drug marketed by Hatchtech and is included in one NDA. It
New patent expiration for Hatchtech drug XEGLYZE Read Post »
New patent expiration for United Therap drug ORENITRAM
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA.
New patent expiration for United Therap drug ORENITRAM Read Post »
New patent expiration for Abbvie drug ORILISSA
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It
